HYFT (MindWalk Holdings) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HYFT MindWalk Holdings Corp HYFT
33 GF Score
Price $1.46
GF Value $0.62
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings FFO?

FFO (Funds from operations) only applies to REITs.

HYFT
33GF Score
MindWalk Holdings Corp HYFT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MindWalk Holdings (HYFT) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of $1.46 is trading 135.5% above its estimated GF Value™ of $0.62. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for HYFT:

  • FFO:
  • GF Value™: $0.62 vs. price of $1.46 (135.5% above fair value)
  • GF Score™: 33/100 with 5 warning signs

No single metric tells the full story. See the HYFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MindWalk Holdings Business Description

Other Exchanges TQB0:Germany
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
33GF Score

Get the complete analysis for HYFT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$0.62
GF Value